Key Findings:  The endocannabinoid system represents a unique target for the treatment of sepsis.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  United States
Year of Pub:  2015
Cannabinoids Studied:  Anandamide (AEA)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB2, PPAR - Alpha
Citation:  Swaminathan S, et al. Emerging therapeutic targets of sepsis-associated acute kidney injury. Semin Nephrol. 2015; 35:38-54. doi: 10.1016/j.semnephrol.2015.01.005
Authors:  Swaminathan S, Rosner MH, Okusa MD